Santen Pharmaceutical News

Santen Pharmaceutical: Corporate Governance Report

Jul 1 17:30

Santen Pharmaceutical: Corporate Governance Report 07/01/2024

Jul 1 16:26

Santen Pharmaceutical: Santen announces the status of their share buyback.

Jul 1 15:00

Santen Pharmaceutical: Announcements of individual stock buyback status.

Jul 1 15:00

Santen Pharmaceutical: Interim report

Jun 26 08:45

Santen Pharmaceutical: Announcements of individual stocks regarding disposal of treasury stock as share-based compensation with transfer restrictions.

Jun 25 16:00

Santen Pharmaceutical: Announcements of individual stocks regarding the disposal of treasury stocks based on stock-linked compensation program.

Jun 25 16:00

Santen Pharmaceutical: Extraordinary Report

Jun 25 14:57

Santen Pharmaceutical: Internal Control Report - 112 (2023/04/01 - 2024/03/31)

Jun 25 14:47

Santen Pharmaceutical: Confirmation letter

Jun 25 14:46

Santen Pharmaceutical: Securities Report - 112th Period (April 1, 2023 to March 31, 2024)

Jun 25 14:45

Santen Pharmaceutical: Treasury stock purchase status report (based on Act Section 24-6 (1))

Jun 14 09:43

Santen Pharmaceutical: Change Report (Stock Certificates Eligible for Special Provisions, etc.)

Jun 6 12:24

Santen Pharmaceutical: Santen announces the status of its stock buyback

Jun 3 15:00

Santen Pharmaceutical: Notice regarding the status of share buybacks

Jun 3 15:00

Santen Pharmaceutical: financial statements

May 28 07:00

Santen Pharmaceutical: business report

May 28 07:00

Santen Pharmaceutical: Notice of the 2024 Convocation Annual General Meeting

May 28 07:00

Santen Pharmaceutical: Independent Officer Notification Form

May 27 16:00

Santen Pharmaceutical: Partial amendments to the convocation notice

May 27 07:00